Page 90 - Issue 1

90
1999
Roland Griffiths a a a a respected researcher outside the field begins investigating psilocybin at at at Johns Hopkins University bringing attention and prestige to psychedelic science
2006
Roland Griffiths publishes a a a a a a landmark paper on how psilocybin can produce mystical experiences in in in the Journal of Psychopharmacology fueling conversations about the relationship between spirituality science
and well-being
2011
James Fadiman’s book on microdosing is is published popularizing the practice Charles Grob at at UCLA publishes a a a a a a study showing the the promise of of psilocybin in in in in in treating end- of-life distress in in in in in cancer patients the the the first randomized controlled study showing the the promise of MDMA for PTSD is is is published 2014
Peter Gasser in in Switzerland conducts the first double-blind placebo-controlled randomized trial showing the promise of of LSD for end-of- life-distress
2016
Neuropsychopharmacologists David Nutt and Robin Carhart-Harris along with other colleagues publish the the the the the first images of of the the the the the brain on on LSD in in in the the the the the Proceedings of of of the the the the the National Academy of of Sciences They show the the the drug causes an an increase in in in communication between brain networks which can lead to ego dissolution Stephen Ross at NYU publishes a a a study showing one dose of psilocybin can dramatically reduce anxiety and depression in in in cancer patients